Status:
UNKNOWN
BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success
Lead Sponsor:
Meir Medical Center
Conditions:
Ectopic Pregnancy
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The investigators want to compeer BHCG levels after Methotrexate ( MTX). treatment for Ectopic pregnancy in days 4 and 7 after MTX. to day 10 . The hypothesis is that "BHCG" level in day 10 is the bes...
Eligibility Criteria
Inclusion
- patients with ectopic pregnancy
- healthy
- hemodynamic stable
- first ectopic
Exclusion
- hemodynamic non-stable
- abnormal liver or kidney function
- allergy reaction to MTX
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01860690
Start Date
November 1 2011
End Date
February 1 2014
Last Update
May 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Zvi Klein
Kfar Saba, Israel